TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”

With strong 1-year returns and upside potential, RAPT Therapeutics, Inc. (NASDAQ:RAPT) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy” A dose bottle of the medication is in the medical tech's hand On December 18, 2025, The Fly reported that TD Cowen initiated coverage of RAPT Therapeutics, Inc. (NASDAQ:RAPT) with a “Buy.” The bullish stance reflects the potential of the company’s lead candidate, o ...